The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro

Chemotherapy
T IchimiyaM Nasu

Abstract

The influence of azithromycin on biofilm formation by Pseudomonas aeruginosa, a cause of refractory chronic respiratory tract infection, was investigated. Alginic acid produced by a mucoid strain of P. aeruginosa was quantified by high-performance liquid chromatography from colonies growing on an agar medium. Polysaccharides in the biofilm formed on silicon chips by a nonmucoid strain were determined by a tryptophan reaction. The effect of azithromycin was examined at concentrations below the minimum inhibitory concentration (sub-MIC) for each strain. Azithromycin significantly inhibited the production of alginic acid from the mucoid strain at > or = 1/256 MIC, and the production of exopolysaccharides from the nonmucoid strain at > or = 1/16 MIC. The inhibition of biofilm formation by azithromycin was also observed by scanning electron microscopy. These findings suggest that azithromycin inhibits biofilm formation by P. aeruginosa at concentrations well below the MIC.

Citations

Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Joanne M WolterJoseph G McCormack
Feb 19, 2010·Applied Microbiology and Biotechnology·Paolo LandiniReindert Nijland
Apr 2, 2008·Current Infectious Disease Reports·Thomas Bjarnsholt, Michael Givskov
Jun 12, 2008·Clinical Reviews in Allergy & Immunology·David P NicholsJames F Chmiel
Sep 7, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·David ShitritMordechai R Kramer
Jun 30, 2009·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Alan G ChengDwight T Jones
Sep 28, 2001·International Journal of Antimicrobial Agents·J C Pechère
Jul 27, 2011·Chemical Reviews·Diego RomeroRoberto Kolter
Oct 30, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Eric C WuRobert M Q Shanks
Oct 24, 2002·Current Opinion in Pulmonary Medicine·Thao NguyenMark A Gill
Mar 16, 2007·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Thomas Bjarnsholt, Michael Givskov
Aug 11, 2010·Antimicrobial Agents and Chemotherapy·Marie Tré-HardyJean-Paul Dehaye
Jul 23, 2008·Antimicrobial Agents and Chemotherapy·Mette E SkindersoeMichael Givskov
Feb 4, 2009·Antimicrobial Agents and Chemotherapy·Xavier MuletAntonio Oliver
Mar 17, 2010·Antimicrobial Agents and Chemotherapy·David J FeolaBrian S Murphy
Sep 14, 2011·Antimicrobial Agents and Chemotherapy·H MaezonoS Ebisu
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Paul BeringerMark Gill
Apr 28, 2006·Antimicrobial Agents and Chemotherapy·Yusuf NalcaSusanne Häussler
Jul 9, 2010·Clinical Microbiology Reviews·Soichiro Kanoh, Bruce K Rubin
Dec 8, 2004·Journal of Clinical Microbiology·Richard J Gillis, Barbara H Iglewski
Apr 4, 2003·American Journal of Respiratory and Critical Care Medicine·Susan G GerhardtJonathan B Orens
Aug 10, 2010·American Journal of Respiratory and Critical Care Medicine·Grant W WatererRichard G Wunderink
Aug 14, 2012·BMC Medicine·Patrick A Flume, Donald R Van Devanter
Feb 12, 2002·Pharmacotherapy·Allyson S Gaylor, Joan C Reilly
Jun 26, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Sean H Ling, Stephan F van Eeden
Sep 24, 2010·Future Microbiology·Christopher D SibleyMichael G Surette
Feb 25, 2010·Natural Product Reports·Jeroen S Dickschat
Feb 16, 2010·Expert Opinion on Investigational Drugs·D M MurphyC Ward
Apr 27, 2010·Paediatric Respiratory Reviews·Abdullah A Yousef, Adam Jaffe
Dec 21, 2007·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kazuhiro TatedaKeizo Yamaguchi
May 1, 2007·Clinics in Chest Medicine·James F Chmiel, Michael W Konstan
May 1, 2007·Clinics in Chest Medicine·John R McArdle, Jaideep S Talwalkar
Nov 3, 2005·Clinics in Chest Medicine·Timothy P M Whelan, Marshall I Hertz
Jun 28, 2005·Pharmacotherapy·William A Prescott, Cary E Johnson
May 23, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A G N RobertsonC Ward
Jul 16, 2009·Environmental Microbiology·Rustam I Aminov
Sep 24, 2015·Current Biology : CB·Nicole Vega, Jeff Gore
Mar 25, 2015·Journal of the American Society for Mass Spectrometry·Vanessa V PhelanPieter C Dorrestein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.